Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL ALEXANDRE TRONEL PHARMACIEN : revenue, balance sheet and financial ratios

SPFPL ALEXANDRE TRONEL PHARMACIEN is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LYON (69008), this company of category PME shows in 2023 a net income positive of 106 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL ALEXANDRE TRONEL PHARMACIEN (SIREN 883093957)
Indicator 2023 2021
Revenue N/C N/C
Net income 106 167 € -31 199 €
EBITDA -2 970 € -21 915 €
Net margin N/C N/C

Revenue and income statement

In 2023, SPFPL ALEXANDRE TRONEL PHARMACIEN generates positive net income of 106 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

EBITDA (2023) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 970 €

EBIT (2023) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-2 970 €

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

106 167 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 38%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.2 years of cash flow to repay all financial debt. This ratio remains within usual banking standards.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

38.231%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

71.938%

Repayment capacity (2023) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

3.245

Solvency indicators evolution
SPFPL ALEXANDRE TRONEL PHARMACIEN

Sector positioning

Debt ratio
38.23 2023
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good -6 pts over 2 years

In 2023, the debt ratio of SPFPL ALEXANDRE TRONEL PH... (38.23) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
71.94% 2023
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent

In 2023, the financial autonomy of SPFPL ALEXANDRE TRONEL PH... (71.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
3.25 years 2023
2021
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Good +22 pts over 2 years

In 2023, the repayment capacity of SPFPL ALEXANDRE TRONEL PH... (3.25) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1193.65. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1193.654

Interest coverage (2023) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-23.367

Liquidity indicators evolution
SPFPL ALEXANDRE TRONEL PHARMACIEN

Sector positioning

Liquidity ratio
1193.65 2023
2021
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Excellent +69 pts over 2 years

In 2023, the liquidity ratio of SPFPL ALEXANDRE TRONEL PH... (1193.65) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-23.37x 2023
2021
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average

In 2023, the interest coverage of SPFPL ALEXANDRE TRONEL PH... (-23.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 700 days. Excellent situation: suppliers finance 700 days of the operating cycle (retail model).

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

700 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPL ALEXANDRE TRONEL PHARMACIEN

Positioning of SPFPL ALEXANDRE TRONEL PHARMACIEN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SPFPL ALEXANDRE TRONEL PHARMACIEN is estimated at 1 252 714 € (range 761 835€ - 1 761 036€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
761k€ 1252k€ 1761k€
1 252 714 € Range: 761 835€ - 1 761 036€
NAF 5 année 2023

Valuation method used

Net Income Multiple
106 167 € × 11.8x = 1 252 715 €
Range: 761 836€ - 1 761 036€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SPFPL ALEXANDRE TRONEL PHARMACIEN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SPFPL ALEXANDRE TRONEL PHARMACIEN

What is the revenue of SPFPL ALEXANDRE TRONEL PHARMACIEN ?

The revenue of SPFPL ALEXANDRE TRONEL PHARMACIEN is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL ALEXANDRE TRONEL PHARMACIEN profitable?

Yes, SPFPL ALEXANDRE TRONEL PHARMACIEN generated a net profit of 106 k€ in 2023.

Where is the headquarters of SPFPL ALEXANDRE TRONEL PHARMACIEN ?

The headquarters of SPFPL ALEXANDRE TRONEL PHARMACIEN is located in LYON (69008), in the department Rhone.

Where to find the tax return of SPFPL ALEXANDRE TRONEL PHARMACIEN ?

The tax return of SPFPL ALEXANDRE TRONEL PHARMACIEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL ALEXANDRE TRONEL PHARMACIEN operate?

SPFPL ALEXANDRE TRONEL PHARMACIEN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.